Chemotherapy, targeted therapies, immunotherapies and hormone therapies can cause fingernail and toenail damage, leading to pain, infection and even nail detachment.

The type and severity of nail damage during cancer therapy can vary widely. Most intravenous (IV) treatments can cause ridging of the nails (Beau’s lines) and pigmentation changes (Melanonychia), which often correspond with the timing of treatment cycles.

Polybalm® is specifically formulated to protect and repair cancer therapy patients’ nails. It nourishes and protects nails from distressing side effects of cancer therapy.

Polybalm’s all-natural formulation includes polyphenol-rich ingredients, providing anti-inflammatory and antioxidant properties. These qualities, combined with its antimicrobial features, contribute to preventing infections.